Previous close | 444.50 |
Open | 0.00 |
Bid | 0.00 x 0 |
Ask | 0.00 x 0 |
Day's range | 0.00 - 0.00 |
52-week range | |
Volume | |
Avg. volume | N/A |
Market cap | 1.175B |
Beta (5Y monthly) | 0.86 |
PE ratio (TTM) | 0.18 |
EPS (TTM) | 25.40 |
Earnings date | 18 Apr 2023 - 24 Apr 2023 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Strong local presence, improving top line, membership hike and significant new contracts in its government business poise Elevance Health (ELV) well for growth.
INDIANAPOLIS, March 09, 2023--Elevance Health (NYSE: ELV) will host an Investor Conference with analysts and investors on March 23, 2023 in New York City. The event will feature presentations and Q&A sessions with the company’s senior leadership team.
UnitedHealth, Elevance Health, Humana and Centene are included in this Analyst Blog.